Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $236k | 17M | 0.01 |
| 2025-06-30 | $40M | 35M | 1.14 |
| 2025-03-31 | $57M | 44M | 1.28 |
| 2024-12-31 | $53M | 49M | 1.08 |
| 2024-09-30 | $50M | 42M | 1.19 |
| 2024-06-30 | $47M | 42M | 1.11 |
| 2024-03-31 | $41M | 42M | 0.97 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1